Innovative Therapeutic Approaches for Huntington’s Disease: From Nucleic Acids to GPCR-Targeting Small Molecules
Huntington’s disease (HD) is a fatal neurodegenerative disorder due to an extraordinarily expanded CAG repeat in the huntingtin gene that confers a gain-of-toxic function in the mutant protein. There is currently no effective cure that attenuates progression and severity of the disease. Since HD is...
Guardado en:
Autor principal: | Hidetoshi Komatsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2217b25787834be19aa97864abe74638 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Journal of Huntington's disease
-
Oligonucleotides
Publicado: (2003) -
Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?
por: Luisana Villegas, et al.
Publicado: (2021) -
The Utility of BDNF Detection in Assessing Severity of Huntington’s Disease
por: Klaudia Plinta, et al.
Publicado: (2021) -
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
por: Craig S. McIntosh, et al.
Publicado: (2021)